The clearance of theophylline is increased during the initial period of tuberculosis treatment

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 6, 2003, Pages 587-591

  Ahn, H C ^a   Lee, Yong Chul ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Anti tuberculosis agents; Pharmacokinetics; Theophylline

Indexed keywords

AMINOPHYLLINE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; THEOPHYLLINE DERIVATIVE;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG HALF LIFE; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTITUBERCULAR AGENTS; BRONCHODILATOR AGENTS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; HUMANS; ISONIAZID; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRAZINAMIDE; RIFAMPIN; THEOPHYLLINE; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 0037834609     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Weinberger M M, Bronsky E A. Evaluation of oral broncho dilator therapy in asthmatic children. J Pediatr 1974; 84: 421-427.
2. Kidney J, Dominguez M, Taylor P M, Rose M, Chung K F, Barnes P J. Immunomodulation by theophylline in asthma, demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995; 151: 1907-1914.
3. Scordamaglia A, Ciplandi G, Ruffoni S, et al. Theophylline and the immune response in vivo and in vitro effects. Clin Immunol Immunopathol 1988; 48: 238-246.
4. Dlugovitzky D, Huber K, Welker G, Molteni O. T-lymphocyte subsets evaluation in patients with tuberculosis using modulation with theophylline. Rev Inst Med Trop Sao Paulo 1991; 33: 105-113.
5. Aubier M. Effect of theophylline on diaphragmatic and other skeletal muscles. J Allergy Clin Immunol 1986; 78: 787-792.
6. Murciano D, Audier M, Lecocguic Y, Pariente R. Effects of theophylline of diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N Engl J Med 1984;311:349-354.
7. Hendeles L, Harman E, Huang D, O Brien R, Blake K, Delafuente J. Theophylline attenuation of airway responses to allergen, comparison with cromolyn metered-dose inhaler. J Allergy Clin Immunol 1995; 95: 505-514.
8. Paloucek F P, Rodvold K A. Evaluation of theophylline overdoses and toxicities. Ann Emerg Med 1988; 17: 135-144.
9. Robson R A, Miners J O, Matthews A P, et al. Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical study. Biochem Pharmacol 1988; 37: 1651-1659.
10. Trissel L A. Aminophylline. 8th ed. In: Handbook on injectable drugs. Bethesda, MD: American Society of Health System Pharmacists, 1994: p 52.
11. Gillum J G, Sesler J M, Bruzzese V L, IsraeI D S, Polk R E. Induction of theophylline clearance by rifampin and rifabutin in healthy male volunteers. Antimicrob Agents Chemother 1996; 40: 1866-1869.
12. Boyce E G, Dukes G E, Rollins D E, Sudds T W. The effect of rifampin on theophylline kinetics. J Clin Pharmacol 1986; 26: 696-699.
13. Torrent J, Izquierdo I, Cabezas R, Jane F. Theophylline-isoniazid interaction. DICP 1989; 23: 143-145.
14. Ahn H C, Yang J H, Lee H B, Rhee Y K, Lee Y C. Effect of anti-tuberculosis agents on theophylline pharmacokinetics. Int J Tuberc Lung Dis 2000; 4: 784-787.
15. McEvoy G K. Antituberculosis agents. In: AHFS Drug Information. Bethesda, MD: American Society of Health System Pharmacists, 2002: pp 482-526.
16. Lacarelle B, Pisano P, Gauthier T, et al. Abbott PKS system, a new version for applied pharmacokinetics including Bayesian estimation. Int J Bio-Med Comput 1994; 36: 127-130.
17. Ratanasavanh D, Berthou F, Dreano Y, Mondine P, Guillouzo A, Riche C. Methylcholanthrene but not phenobarbital enhances caffeine and theophylline metabolism in cultured adult human hepatocytes. Biochem Pharmacol 1990; 39: 85-94.
18. Bachmann K A, Kauregui L. Use of single sample clearance estimates of cytochrome P450 substrates to chracterize human hepatic CYP status in vivo. Xenobiotica 1993; 23: 307-315.
19. Pea F, Furlanut M. Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions. Clin Pharmacokinet 2001; 40: 833-868.
20. Wen X, Wang J S, Neuvoren P J, Backman J T. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes. Eur J Clin Pharmacol 2002; 57: 799-804.
21. Samigun, Mulyono, Santoso B. Lowering of theophylline clearance by isoniazid in slow and rapid acetylators. Br J Clin Pharmacol 1990; 29: 570-573.
22. Branch R A, Adedoyin A, Frye R F, Wilson J W, Romakes M. In vivo modulation of CYP enzymes by quinidine and rifampin. Clin Pharmacol Ther 2000; 68: 401-411.
23. Garg S K, Dhand R, Malik S K, et al. Single dose kinetics of rifampicin and isoniazid in well nourished and malnourished patients of tuberculosis. Int J Clin Pharmacol Ther Toxicol 1988; 26: 417-420.
24. Zhang J N, Liu X G, Zhu M, Chiu F C, Li R C. Assessment of presystemic factors on the oral bioavailability of rifampicin following multiple dosing. J Chemoth 1998; 10: 354-359.
25. Strolin Beneditti M, Dostert P. Induction and autoinduction properties of rifampicin derivatives: a review of animal and human studies. Environ Health Perspect 1994; 102: 101-105.
26. Mouton R P, Mattie H, Swart K, Kreukniet J, de Wael J. Blood levels of rifampicin, desacetylrifampicin and isoniazide during combined therapy. J Antimicrob Chemother 1979; 5: 447-454
27. Fuhr U, Doehmer J, Battula N, et al. Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Biochem Pharmacol 1992; 43: 225-235.
28. Sarkar M A, Jackson B J. Theophylline N-demethylations as probes for P4501A1 and P4501A2. Drug Metab Dispos 1994; 22: 827-834.
29. Tjia J F, Colbert J, Back D J. Theophylline metabolism in human liver microsomes: inhibition studies. J Pharmacol Exp Ther 1996; 276: 912-917.
30. Straughn A B, Henderson R P, Lieberman P L, Self T H. Effect of rifampin on theophylline disposition. Ther Drug Monit 1984; 6: 153-156.
31. Powell-Jackson P R, Jamieson A P, Gray B J, Moxhan J, Williams R. Effect of rifampicin administration on theophylline pharmacokinetics in humans. Am Rev Respir Dis 1985; 131: 939-940.
32. Robson R A, Miners J O, Wing L M, Birkett D J. Theophylline-rifampicin interaction; non-selective induction of theophylline metabolic pathways. Br J Clin Pharmacol 1984; 18: 445-448.